CARL ZEISS MEDITEC ADR 1 Logo
US14218T1051
A0YGQ7
CZMWY

CARL ZEISS MEDITEC ADR 1

Caricamento quotazioni...

Previsioni

Acquista
  1
Mantieni
  2
Vendi
  1

  • Carl Zeiss Meditec: investment ten years ago would mean around 25% loss

    An investment of EUR 100 in Carl Zeiss Meditec ten years ago would today have resulted in 2.916 shares and was worth only EUR 74.82 as of 20 May 2026, corresponding to a performance of −25.18%. The market value of all Carl Zeiss Meditec shares most recently stood at EUR 2.21 billion. Calculation does not take into account stock splits or dividends. » Altro su finanzen.net


  • Carl Zeiss Meditec rises after announcement of extensive cost cuts

    Shares of Carl Zeiss Meditec jumped sharply after initially volatile trading on Tuesday, trading 7.4 percent higher at €27.46 around midday. Investors reacted positively to announced cost cuts and an ongoing restructuring that UBS analyst Graham Doyle called groundbreaking. In the short term the stock climbed above the 21‑day line, but the longer‑term downtrend in place since 2012 remains intact. » Altro su de.investing.com


  • Carl Zeiss Meditec recovers after cautiously optimistic comment from Goldman Sachs

    After cautiously optimistic remarks from Goldman Sachs, Carl Zeiss Meditec’s shares rose by up to 5% on Tuesday and were trading at €25.64 in the morning. Analyst Richard Felton sees short-term upside potential due to expected cost savings and a more coherent portfolio, and a possible reinstatement of the fiscal 2026 targets in upcoming quarterly results. The stock had fallen two weeks earlier to its lowest level since 2015; earnings estimates for 2026–2028 have been cut by 22–29% since the start of the year. » Altro su de.investing.com

Nel 2026, CARL ZEISS MEDITEC ADR 1 ha già distribuito 0,53 € di dividendi. L'ultimo pagamento è avvenuto a aprile.

Dati finanziari dell'azienda

Nell'ultimo trimestre, CARL ZEISS MEDITEC ADR 1 ha registrato ricavi pari a 562,72 Mln € e un utile netto di 55,03 Mln €
(EUR) giugno 2026
YoY
Ricavi 562,72 Mln 2,38%
Utile lordo 302,28 Mln 4,34%
Utile netto 55,03 Mln 93,94%
EBITDA 74,87 Mln 31,20%

Dati fondamentali

Metrica Valore
Capitalizzazione di mercato
2,85 Mld €
Numero di azioni
87,54 Mln
Massimo/minimo a 52 settimane
48,34 € - 23,03 €
Rendimento da dividendo
1,65%
Dividendi TTM
0,53 €
Beta
1,46
Rapporto P/E
19,29
Rapporto PEG
-5,56
Rapporto P/B
1,32
Rapporto P/S
1,07

Profilo aziendale

Die Carl Zeiss Meditec AG ist als Medizintechnikunternehmen in Deutschland, dem übrigen Europa, den Vereinigten Staaten, Asien und international tätig. Es ist in zwei Segmenten tätig, Ophthalmic Devices und Microsurgery. Das Segment Ophthalmic Devices bietet Produkte und Lösungen für die Diagnose und Behandlung von Augenkrankheiten sowie Systeme und Verbrauchsmaterialien für Katarakt-, Netzhaut- und refraktive Operationen an. Das Unternehmen beliefert praktizierende Ophthalmologen und Optometristen sowie Ärzte und Chirurgen in Krankenhäusern und ambulanten Operationszentren. Das Segment Mikrochirurgie bietet Visualisierungslösungen für invasive chirurgische Behandlungen sowie Lösungen in den Bereichen Hals-, Nasen- und Ohrenheilkunde, plastische und rekonstruktive Chirurgie, Zahn- und Wirbelsäulenchirurgie. Das Unternehmen beliefert Ärzte in verschiedenen Bereichen und Krankenhäuser. Das Unternehmen wurde 1846 gegründet und hat seinen Hauptsitz in Jena, Deutschland. Die Carl Zeiss Meditec AG ist eine Tochtergesellschaft der Carl Zeiss AG.

Nome
CARL ZEISS MEDITEC ADR 1
CEO
Andreas Pecher
Sede centrale Jena, th
Germania
Sito web
Settore
Sanità
Industria
Attrezzature e forniture sanitarie
Quotazione in borsa
03/08/2012
Dipendenti 5784

Simboli di borsa

Borsa Simbolo
Pnk
CZMWY
Frankfurt
AFXA.F
Düsseldorf
AFXA.DU
München
AFXA.MU

Scopri gli asset

Gli azionisti di CARL ZEISS MEDITEC ADR 1 investono anche nei seguenti asset

🍪

Parqet  usa i cookie. Scopri di più